OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel
N. Eric Olson, Seamus P. Ragan, David J. Reiss, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 3, pp. 406-418
Open Access | Times Cited: 8
N. Eric Olson, Seamus P. Ragan, David J. Reiss, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 3, pp. 406-418
Open Access | Times Cited: 8
Showing 8 citing articles:
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
Steven Μ. Albelda
Nature Reviews Clinical Oncology (2023) Vol. 21, Iss. 1, pp. 47-66
Closed Access | Times Cited: 171
Steven Μ. Albelda
Nature Reviews Clinical Oncology (2023) Vol. 21, Iss. 1, pp. 47-66
Closed Access | Times Cited: 171
Outcome correlates of approved CD19-targeted CAR T cells for large B cell lymphoma
Timothy Bock, Chanukya K. Colonne, Salvatore Fiorenza, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 1
Timothy Bock, Chanukya K. Colonne, Salvatore Fiorenza, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 1
The Role of the Tumor Microenvironment in T-Cell Redirecting Therapies of Large B-Cell Lymphoma: Lessons Learned from CAR-T to Bispecific Antibodies
Kirill V. Lepik, Vladislav V. Markelov
Cancers (2025) Vol. 17, Iss. 2, pp. 317-317
Open Access
Kirill V. Lepik, Vladislav V. Markelov
Cancers (2025) Vol. 17, Iss. 2, pp. 317-317
Open Access
PD‐L1+ macrophage and tumor cell abundance and proximity to T cells in the pretreatment large B‐cell lymphoma microenvironment impact CD19 CAR‐T cell immunotherapy efficacy
Alexandre V. Hirayama, Jocelyn H. Wright, Kimberly S. Smythe, et al.
HemaSphere (2024) Vol. 8, Iss. 8
Open Access | Times Cited: 3
Alexandre V. Hirayama, Jocelyn H. Wright, Kimberly S. Smythe, et al.
HemaSphere (2024) Vol. 8, Iss. 8
Open Access | Times Cited: 3
Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL
John R. Davies, Laura K. Hilton, Aixiang Jiang, et al.
Blood Advances (2023) Vol. 7, Iss. 20, pp. 6156-6162
Open Access | Times Cited: 5
John R. Davies, Laura K. Hilton, Aixiang Jiang, et al.
Blood Advances (2023) Vol. 7, Iss. 20, pp. 6156-6162
Open Access | Times Cited: 5
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA
Ugo Testa, Germana Castelli, Giuseppe Leone, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2023) Vol. 15, Iss. 1, pp. e2023066-e2023066
Open Access | Times Cited: 4
Ugo Testa, Germana Castelli, Giuseppe Leone, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2023) Vol. 15, Iss. 1, pp. e2023066-e2023066
Open Access | Times Cited: 4
Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey‐Holden Prostate Cancer Academy Meeting
Andrea K. Miyahira, Sophia C. Kamran, Tamara Jamaspishvili, et al.
The Prostate (2024) Vol. 84, Iss. 11, pp. 993-1015
Closed Access | Times Cited: 1
Andrea K. Miyahira, Sophia C. Kamran, Tamara Jamaspishvili, et al.
The Prostate (2024) Vol. 84, Iss. 11, pp. 993-1015
Closed Access | Times Cited: 1
What Is Dark Zone Lymphoma and Is It Clinically Relevant?
Brett Collinge, David W. Scott
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, pp. S121-S123
Closed Access
Brett Collinge, David W. Scott
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, pp. S121-S123
Closed Access
